Loading insider details...
Beta
Latest Form 4 (Jan 8, 2026): Grant/Award of 142,500 CLYM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 8, 2026 | Climb Bio, Inc. (CLYM) | Grant/Award | 142,500 | n/a |
| Oct 1, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 600,000 | n/a |
| Aug 15, 2024 | Mural Oncology plc (MURA) | Purchase | 10,000 | $32.1K |
| Jun 3, 2024 | Mural Oncology plc (MURA) | Grant/Award | 8,462 | $28.3K |
| Jan 23, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/Award | 81,065 | n/a |